LMR Partners’s Merck MRK Stock Holding History

LMR Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.93M	Buy	+41,000	New	+$4.73M	0.01%	645

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LMR Partners's MRK Position: Q1 2026 in Review

LMR Partners reduced its Merck (MRK) stake by 90% in Q1 2026, selling an estimated $3.12M and leaving 3,000 shares worth $361K. The position accounts for ﹤0.01% of the portfolio, ranked #1118.

LMR Partners first reported a position in MRK in Q2 2014 and has held it in 18 quarters since. The position peaked at $4.28M in Q2 2014. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

LMR Partners held 3,000 shares of Merck worth $361K as of Q1 2026.
LMR Partners sold 27,000 Merck shares in Q1 2026, an estimated $3.12M.
Merck made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1118 holding.
LMR Partners first reported a position in Merck in Q2 2014 and has held it in 18 quarters since.
LMR Partners's Merck position peaked at $4.28M in Q2 2014.
3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.